
|Articles|November 14, 2022
The Way PCR is Changing UTI Diagnostics
Advertisement
As the healthcare industry faces further consolidation and industrialization, private urological practices are navigating the best ways to remain independent and continue to offer personalized, cost-effective, and operationally-efficient care. To remain competitive in this landscape, many of these community-based practice owners are wondering how advances in medical technology can aid them in this goal. It is through this investigation that many are discovering the power and potential of PCR in the treatment of Urinary Tract Infections (UTIs).
Fill out the form to download the whitepaper to learn more:
Sponsored by:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
2
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
3
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
4
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
5






